Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer

Carcinogenesis

Volumn 18, Issue 5, 1997, Pages 967-973

  Wu, Xifeng ^a,b   Shi, Huihui ^a   Jiang, Hong ^a   Kemp, Bonnie ^a   Hong, Waun Ki ^a   Delclos, George L ^b   Spitz, Margaret R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450 ISOENZYME; MUTAGENIC AGENT; NITROSAMINE;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLIC ACTIVATION; MULTIVARIATE ANALYSIS; ONSET AGE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2E1; DISEASE SUSCEPTIBILITY; ETHNIC GROUPS; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MUTAGENS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SMOKING;

EID: 0031425983     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.5.967     Document Type: Article

References (42)

1. Daly, A.K., Chloerton, S., Gregory, W. and Idle, J.R. (1993) Metabolic polymorphisms. Pharmacol. Ther., 57, 129-160.
2. Daly, A.K. (1995) Molecular basis of polymorphic drug metabolism. J. Mol. Med., 73, 539-553.
3. Raunio, H., Husgafvel-Pursiainen, K., Anttila, S., Hietanen, E., Hirvonen, A. and Pelkonen, O. (1995) Diagnosis of polymorphism in carcinogene-activating and inactivating enzymes and cancer susceptibility - a review. Gene, 159, 113-121.
4. Guengerich, F.P., Kim, D.-H. and Iwasaki, M. (1991) Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol., 4, 168-179.
5. Koop, D.R. (1992) Oxidative and reductive metabolism by cytochrome P4502E1. FASEB J., 6, 724-730.
6. Yamazaki, H., Inui, Y., Yun, C., Guengerich, F.P. and Shimada, T. (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis, 13, 1789-1794.
7. Uematsu, F., Kikuchi, H., Motomiya, M., Abe, T., Sagami, I., Ohmachi, T., Wakui, A., Kanamaru, R. and Watanabe, M. (1991) Association between restriction fragment length polymorphism of the human cytochrome P450IIEI gene and susceptibility to lung cancer. Jpn. J. Cancer Res., 82, 254-256.
8. Kato, S., Shields, P.G., Caporaso, N.E., Sugimura, H., Trivers, G.E., Tucker, M.A., Trump, B.F., Weston, A. and Harris, C.C. (1994) Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol. Biomarkers Prev., 3, 515-518.
9. Hayashi, S.I., Watanabe, J. and Kawajiri, K. (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIEI gene. J. Biochem., 110, 559-565.
10. Persson, I., Johansson, I., Bergling, H., Dahl, M., Seidegard, J., Rylander, R., Rannug, A., Hogberg, J. and Sundberg, M.I. (1993) Genetic polymorphism of cytochrome P4502E1 in a Swedish population relationship to incidence of lung cancer. FEBS Lett., 319, 207-211.
11. Hsu, T.C., Johnston, D.A., Cherry, L.M., Ramkisson, D., Schantz, S.P., Jessup, J.M., Winn, R.J., Shirley, L. and Furlong, C. (1989) Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int. J. Cancer, 43, 403-409.
12. Hsu, T.C., Spitz, M.R. and Schantz, S.P. (1991) Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol. Biomarkers Prev., 1, 83-89.
13. Spitz, M.R., Hoque, A., Trizna, Z., Schantz, S.P., Amos, C.I., King, T.M., Bondy, M.L., Hong, W.K. and Hsu, T.C. (1994) Mutagen sensitivity as a risk factor for second malignant tumors following upper aerodigestive tract malignancies. J. Nat. Cancer Inst., 86, 1681-1684.
14. Spitz, M.R., Hsu, T.C., Wu, X., Fueger, J.J., Amos, C.I. and Roth, J.A. (1995) Mutagen sensitivity as a biological marker of lung cancer risk in African-Americans. Cancer Epidemiol. Biomarkes Prev., 4, 99-103.
15. Spitz, M.R., Fueger, J.J., Beddingfield, N.A., Annegers, J.F., Hsu, T.C., Newell, G.R. and Schantz, S.P. (1989) Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res., 49, 4626-4628.
16. Spitz, M.R., Fueger, J.J., Halabi, S., Schantz, S.P., Sample, D. and Hsu, T.C. (1993) Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol. Biomarkers Prev., 2, 329-333.
17. Seree, E.M., Villard, P.H., Re, J.L., De Meo, M., Lacarelle, B., Attolini, L., Dumenil, G., Catalin, J., Durand, A. and Barra, Y. (1996) High inducibility of mouse renal CYP2E1 gene by tobacco smoke and its possible effect on DNA single strand breaks. Biochem. Biophys. Res. Commun., 219, 429-434.
18. Yu, M.W., Gladek-Yarborough, A., Chiamprasert, S., Santella, R.M., Liaw, Y.F. and Chen, C.J. (1995) Cytochrome P450 2E1 and glutathione s-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109, 1266-1273.
19. Maezawa, Y., Yamauchi, M. and Toda, G. (1994) Association between restriction fragment length polymorphism of the human cytochrome P450IIEI gene and susceptibility to alcoholic liver cirrhosis. Am. J. Gastroenterol., 89, 561-565.
20. Woolf, B. (1955) On estimating the relation between blood group and disease. Ann. Hum. Genet., 19, 251-253.
21. STATA Release 3.1 (1993) Reference Manual, 6th edn. STATA Corporation.
22. Harris, C.C. (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res., 51, 5023-5044.
23. Villard, P.H., Seree, E., Lacarelle, B., Therene-Fenoglio, M.C., Barra, Y., Attolini, L., Bruguerole, B., Durand, A. and Catalin, J. (1994) Effect of cigarette smoke on hepatic and pulmonary cytochrome P450 in mouse: evidence for CYP2E1 induction in lung. Biochem. Biophys. Res. Commun., 202, 1731-1737.
24. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., Karjalainen, A. and Vainio, H. (1993) The human CYP2E1 gene and lung cancer: Oral and RsaI restriction fragment length polymorphism in a Finnish study population. Carcinogenesis, 14, 85-88.
25. Jin, X., Wu, X., Roth, J.A., Amos, C.I., King, T.M., Branch, C., Honn, S.E. and Spitz, M.R. (1995) Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis, 16, 2205-2208.
26. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J. and Hayashi, S. (1993) The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol., 14, 77-87.
27. Nakachi, K., Imai, K., Hayashi, S. and Kawajiri, K. (1993) Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53, 2994-2999.
28. McGlynn, K.A. and Buetow, K.H. (1994) Metabolic and H-ras polymorphisms in genetic susceptibility. Cancer Bull., 46, 220-227.
29. Horm, J.W., Asire, A.J., Young, J.L., Jr and Pollack, E.S. (eds) (1984) Cancer Incidence and Mortality in the United States, 1973-1981. SEER program, NIH publication no. 85-1837, USDHHS.
30. Rosenwaike, I. (1988) Cancer mortality among Mexican immigrants in the United States. Public Health Report, 103, 195-201.
31. Centers for Disease Control. (1992) Cigarette smoking among adults: United States, 1990. Morb. Mortal. Wkly Rep., 41, 354-362.
32. United States Department of Health and Human Services. (1989) Reducing the Health Consequences of Smoking: 25 Years of Progress: a Report of the Surgeon General. DHHS Publ. No. CDC 89-8411. US Government Printing Office, Washington, DC.
33. Marcus, A., Shopland, D., Crane, L. and Lynn, W. (1989) Prevalence of cigarette smoking in the United States: estimates from the 1985 Current Population survey. J. Natl. Cancer Inst., 81, 409-414.
34. Haynes, S.G., Harvey, C., Montes, H., Nickens, H. and Cohen, B.H. (1990) Patterns of cigarette smoking among Hispanics in the United States: results from HHANES 1982-1984. Am. J. Publ. Health, 80 (Suppl.), 47-54.
35. Stephens, E.A., Taylor, J.A., Kaplan, N., Yang, C.H., Hsieh, L.L., Lucier, G.W. and Bell, D.A. (1994) Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics, 4, 185-192.
36. Uematsu, F., Ikawa, S., Kikuchi, H., Sagami, I., Kanamaru, R., Abe, T., Satoh, K., Motomiya, M. and Watanabe, M. (1994) Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIEI) gene and susceptibility to lung cancer: possible relavence to low smoking exposure. Pharmacogenetics, 4, 58-63.
37. Ingelman-Sundberg, M., Johansson, I., Persson, I., Yue, Q.Y., Dahl, M.L., Bertilsson, L. and Sjoqvist, F. (1994) Genetic polymorphism of cytochrome P450: interethnic differences and relationship to incidence of lung cancer. Pharmacogenetics, 2, 264-271.
38. Sugimura, H., Hamada, G.S., Suzuki, I., Iwase, T., Kiyokawa, E., Kino, I. and Tsugane, S. (1995) CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil. Pharmacogenetics, 5, S145-148.
39. Watanabe, J., Yang, J.P., Eguchi, H., Hayashi, S., Imai, K., Nakachi, K. and Kawajiri, K. (1995) An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn. J. Cancer Res., 86, 245-248.
40. Kato, S., Shields, P.G., Caporaso, N.E., Hoover, R.N., Trump, B.F., Sugimura, H., Weston, A. and Harris, C.C. (1992) Cytochrome P450IIEI genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res., 52, 6712-6715.
41. Wu, X., Liu, J.H., Trizna, Z. and Spitz, M.R. (1996) The association of N-acetyltransferase (NAT2) slow acetylator, mutagen sensitivity and lung cancer risk. Proc. Amer. Ass. Can. Res., 37, 262.
42. Spitz, M.R., Wu, X.F., Jiang, H., Kelsey, K., Wiencke, J. and Hsu, T.C. (1996) Glutathione S-transferase (GSTM1 & GSTT1) genotypes, mutagen sensitivity, cigarette smoking in lung cancer risk. Proc. Amer. Ass. Can. Res., 37, 252.